- Investigators
- Shane Hester, Ruchir Puri, Jana M Sacco
- Ages
- 22 Years - 99 Years
- Sexes
- All
Clinical trials
-
Study of BD ORC Original Absorbable Hemostat vs. Surgicel簧 Original Absorbable Hemostat -
Study of BD ORC Original Absorbable Hemostat Compared with Surgicel簧 Original Absorbable Hemostat - Investigator
- Kethandapatti Balaji
- Ages
- 22 Years - 101 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
BabyCOVE study - Investigator
- Mobeen H Rathore
- Ages
- 3 Years - 6 Years
- Sexes
- All
-
Validation of Ovarian Adnexal Mass Assessment Score Test System - Investigators
- Isidore D Benrubi, Karina E Hew
- Ages
- 18 Years - 99 Years
- Sexes
- Female
-
A Phase 2/3, Randomized, Controlled, Masked, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Two Doses of AGTC-501, a Recombinant Adeno-associated Virus Vector Expressing RPGR (rAAV2tYF-GRK1-RPGR), Compared to an Untreated Control - Investigator
- Sandeep Grover
- Ages
- 12 Years - 50 Years
- Sexes
- Male
-
The Connection study (20191002) - Investigators
- William R Driscoll, Mark Hudak, Ma Ingyinn, Orlyn C Lavilla, John W Logan, Dawn D McDaniel, Padma S Nandula, Shalinkumar P Patel, Sanket Shah, Renu Sharma, Winston T Sheen
- Ages
- N/A
- Sexes
- All